Quantitative characterization of intact sialylated O-glycans with MALDI-MS for protein biotherapeutics

Korean Journal of Chemical Engineering - Tập 35 - Trang 1462-1467 - 2018
Cheol-Hwan Hwang1, Hae-Min Park2, Han-Gyu Park1, Da-Hee Ahn1, Seong-Min Kim1, Byoung Joon Ko3, Young Hwan Kim4, Yung-Hun Yang5, Yun-Gon Kim1
1Department of Chemical Engineering, Soongsil University, Seoul, Korea
2Department of Chemistry, Northwestern University, Evanston, USA
3New Drug Development Center, Osong Medical Innovation Foundation, Cheongju, Korea
4Biomedical Omics Team, Korea Basic Science Institute (KBSI), Cheongju, Korea
5Department of Biological Engineering, Konkuk University, Seoul, Korea

Tóm tắt

For validating O-glycosylation of protein biotherapeutics, we presented a quantitative O-glycomics method which is based on the neutralization of sialic acids, the specific release of O-glycans, and the introduction of permanent positive charge followed by quantitative MALDI-MS analysis. This method shows excellent technical reproducibility, linearity and sensitivity. In addition, it enables the quantification of intact O-glycans with minimal degradation or loss of sialic acids on these glycans compared to a conventional HPLC-based method. We then applied this method to quantitatively characterize O-glycans present on Etanercept. The analysis showed the relative abundances of mono- and di-sialylated core 1 O-glycans - were 79.3±0.8% and 17.3±1.4%, respectively. This glycomics technology could allow for the reliable quantitative analysis of intact O-glycans from glycoproteins and may contribute to validation of O-glycosylation protein biotherapeutics in the pharmaceutical industry.

Tài liệu tham khảo

S. Elliott, T. Lorenzini, S. Asher, K. Aoki, D. Brankow, L. Buck, L. Busse, D. Chang, J. Fuller, J. Grant, N. Hernday, M. Hokum, S. Hu, A. Knudten, N. Levin, R. Komorowski, F. Martin, R. Navarro, T. Osslund, G. Rogers, N. Rogers, G. Trail and J. Egrie, Nat. Biotechnol., 21, 414 (2003). R. J. Sola and K. Griebenow, BioDrugs, 24, 9 (2010). A. M. Sinclair and S. Elliott, J. Pharm. Sci., 94, 1626 (2005). R. J. Sola and K. Griebenow, J. Pharm. Sci., 98, 1223 (2009). P. Kang, Y. Mechref, Z. Kyselova, J. A. Goetz and M. V. Novotny, Anal. Chem., 79, 6064 (2007). W. A. Tao and R. Aebersold, Curr. Opin. Biotechnol., 14, 110 (2003). G. Alvarez-Manilla, N. L. Warren, T. Abney, J. Atwood, 3rd, P. Azadi, W. S. York, M. Pierce and R. Orlando, Glycobiology, 17, 677 (2007). C. Wang, P. Zhang, W. Jin, L. Li, S. Qiang, Y. Zhang, L. Huang and Z. Wang, J. Proteomics, 150, 18 (2017). M. Toyoda, H. Ito, Y. K. Matsuno, H. Narimatsu and A. Kameyama, Anal. Chem., 80, 5211 (2008). G.C. Gil, B. Iliff, R. Cerny, W. H. Velander and K. E. Van Cott, Anal. Chem., 82, 6613 (2010). H. J. Jeong, M. Adhya, H. M. Park, Y. G. Kim and B. G. Kim, Xenotransplantation, 20, 407 (2013). C. Wang, Z. Wu, J. Yuan, B. Wang, P. Zhang, Y. Zhang, Z. Wang and L. Huang, J. Proteome. Res., 13, 372 (2014). Y. Shinohara, J. Furukawa, K. Niikura, N. Miura and S. Nishimura, Anal. Chem., 76, 6989 (2004). Y.W. Kim, C. Sung, S. Lee, K. J. Kim, Y. H. Yang, B. G. Kim, Y. K. Lee, H. W. Ryu and Y. G. Kim, Anal. Chem., 87, 858 (2015). K. J. Kim, H. J. Kim, H. G. Park, C. H. Hwang, C. Sung, K. S. Jang, S. H. Park, B. G. Kim, Y. K. Lee, Y. H. Yang, J. H. Jeong and Y. G. Kim, Sci. Rep., 6, 24489 (2016). K. J. Kim, Y. W. Kim, C. H. Hwang, H. G. Park, Y. H. Yang, M. Koo and Y. G. Kim, Biotechnol. Lett., 37, 2019 (2015). L. Liu, S. Gomathinayagam, L. Hamuro, T. Prueksaritanont, W. Wang, T. A. Stadheim and S. R. Hamilton, Pharm. Res., 30, 803 (2013). D. Pennica, V. T. Lam, R. F. Weber, W. J. Kohr, L. J. Basa, M. W. Spellman, A. Ashkenazi, S. J. Shire and D. V. Goeddel, Biochemistry, 32, 3131 (1993). M. DiPaola, J. Li and E. Stephens, J. Bioanal. Biomed., 5, 5 (2013). S. Houel, M. Hilliard, Y. Q. Yu, N. McLoughlin, S. M. Martin, P. M. Rudd, J. P. Williams and W. Chen, Anal. Chem., 86, 576 (2014).